Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sandoz has announced plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe.
read more
Wednesday, April 16, 2014
Patheon , the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and ...
read more
From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.
read more
Sartorius Stedim Biotech (SSB), an international supplier for the biopharmaceutical industry, has announced the launch of a full range of chemistry testing services.
read more
Wednesday, April 11, 2018
Evotec AG announced a strategic collaboration with Petra Pharma Corporation.
read more
Asymchem announced its Tianjin1 site successfully completed a FDA general GMP reinspection conducted between January 14-18, 2019. No Form 483 was issued.
read more
Worldwide Clinical Trials has opened a new, larger depot site in St. Petersburg, Russia. The spacious, new facility – at 1,300 square meters in size – allows for the storage and distribution of a wide range of clinical trial materials with special ...
read more
Leiters has been awarded an outsourcing supply agreement for 503B compounded pharmaceuticals. The 3-year agreement went into effect on June 1, 2018.
read more
Mikart and Benuvia Operations announced a strategic co-marketing partnership to provide fully integrated, end-to-end solutions spanning drug substance (API) development through finished drug product manufacturing.
read more
FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the COVID-19 pandemic.
read more
Pierre Fabre announced a purchase agreement to acquire several assets from biotechnology company Igenica Biotherapeutics.
read more
Tuesday, February 25, 2020
The Secretary of HHS has delegated to FDA the authority to determine whether particular tests are "simple" and have "an insignificant risk of an erroneous result" under the CLIA of 1988 and are thus eligible for waiver categorization.
read more
Monday, December 11, 2017
Mallinckrodt has closed the acquisition of Ocera Therapeutics, a clinical stage biopharmaceutical company.
read more
Trenchant BioSystems and Invetech have entered into a strategic alliance which will collaborate on the continued development of Trenchant’s fully automated AutoCell Platform, intended for future commercialization.
read more
IDT Biologika and Exothera announced a collaboration to develop a large-scale manufacturing process for viral vector-based vaccines. The feasibility study is focussing on Modified Vaccinia Ankara (MVA) virus as a first example for IDT’s broad range ...
read more